^"Human PubMed Reference:". National Center for Biotechnology Information, U.S. National Library of Medicine.
^"Mouse PubMed Reference:". National Center for Biotechnology Information, U.S. National Library of Medicine.
^Cawthon RM, Andersen LB, Buchberg AM, Xu GF, O'Connell P, Viskochil D, Weiss RB, Wallace MR, Marchuk DA, Culver M, et al. (Jun 1991). "cDNA sequence and genomic structure of EV12B, a gene lying within an intron of the neurofibromatosis type 1 gene". Genomics. 9 (3): 446–60. doi:10.1016/0888-7543(91)90410-G. hdl:2027.42/29439. PMID1903357.
Xu G, O'Connell P, Stevens J, White R (1992). "Characterization of human adenylate kinase 3 (AK3) cDNA and mapping of the AK3 pseudogene to an intron of the NF1 gene". Genomics. 13 (3): 537–42. doi:10.1016/0888-7543(92)90122-9. PMID1639383.
Cawthon RM, Weiss R, Xu GF, et al. (1990). "A major segment of the neurofibromatosis type 1 gene: cDNA sequence, genomic structure, and point mutations". Cell. 62 (1): 193–201. doi:10.1016/0092-8674(90)90253-B. PMID2114220. S2CID8201518.
Douglas J, Cilliers D, Coleman K, et al. (2007). "Mutations in RNF135, a gene within the NF1 microdeletion region, cause phenotypic abnormalities including overgrowth". Nat. Genet. 39 (8): 963–5. doi:10.1038/ng2083. PMID17632510. S2CID35797973.